The efficacy of any advanced chemical intermediate lies in its carefully designed molecular architecture and predictable reactivity. N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, bearing the CAS number 231278-20-9, is a prime example of such precision engineering in chemical synthesis. Understanding its structure – featuring a quinazoline ring system, a chlorinated and fluorinated aromatic ring linked by an ether, and an iodine substituent – is key to appreciating its role in creating complex pharmaceutical compounds. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of producing this molecule with the highest fidelity.

The reactivity of N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine is largely dictated by its functional groups. The iodine atom, for instance, is a common leaving group or can be involved in cross-coupling reactions, while the amine on the quinazoline ring offers sites for further derivatization. These characteristics make it an indispensable building block for chemists engaged in creating novel drug candidates. NINGBO INNO PHARMCHEM CO.,LTD. ensures that the synthesis processes used to produce this intermediate preserve these crucial reactive sites, guaranteeing optimal performance in subsequent chemical steps. This focus on structure and reactivity is what allows researchers to buy N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine with confidence.

The strategic placement of substituents on the phenyl ring, such as the chlorine atom and the 3-fluorobenzyloxy group, also influences the molecule's electronic properties and its interaction within biological systems, which is critical when it's used as a Lapatinib intermediate. As NINGBO INNO PHARMCHEM CO.,LTD. continues to manufacture N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, we remain committed to providing researchers with the detailed chemical insights needed to maximize its potential in groundbreaking scientific endeavors.